Literature DB >> 7798275

Novel approach to molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase.

S Shuman1.   

Abstract

Construction of chimaeric DNA molecules in vitro relies traditionally on two enzymatic steps catalyzed by separate protein components. Site-specific restriction endonucleases are used to generate linear DNAs with defined termini that can then be joined covalently at their ends via the action of DNA ligase. A novel approach to the synthesis of recombinant DNAs exploits the ability of a single enzyme, vaccinia DNA topoisomerase, to both cleave and rejoin DNA strands with extreme specificity at each step. Placement of the CCCTT cleavage motif for vaccinia topoisomerase near the end of a duplex DNA permits efficient generation of a stable, highly recombinogenic protein-DNA adduct that can religate only to acceptor DNAs that contain complementary single-strand extensions. Linear DNAs containing CCCTT cleavage sites at both ends (bivalent substrates) can be activated by topoisomerase and inserted into a plasmid vector in a simple and rapid in vitro procedure that is especially well suited to the molecular cloning of polymerase chain reaction-amplified DNAs. Activation of polyvalent (e.g. branched) DNA substrates by topoisomerase offers a potentially powerful method for the synthesis of two- and three-dimensional polynucleotide networks.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7798275

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  DNA strand transfer catalyzed by vaccinia topoisomerase: ligation of DNAs containing a 3' mononucleotide overhang.

Authors:  C Cheng; S Shuman
Journal:  Nucleic Acids Res       Date:  2000-05-01       Impact factor: 16.971

2.  Genome-scale cloning and expression of individual open reading frames using topoisomerase I-mediated ligation.

Authors:  J A Heyman; J Cornthwaite; L Foncerrada; J R Gilmore; E Gontang; K J Hartman; C L Hernandez; R Hood; H M Hull; W Y Lee; R Marcil; E J Marsh; K M Mudd; M J Patino; T J Purcell; J J Rowland; M L Sindici; J P Hoeffler
Journal:  Genome Res       Date:  1999-04       Impact factor: 9.043

3.  Recombinogenic flap ligation pathway for intrinsic repair of topoisomerase IB-induced double-strand breaks.

Authors:  C Cheng; S Shuman
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  Expression and functional characterization of a nucleotide sugar transporter from Drosophila melanogaster: relevance to protein glycosylation in insect cell expression systems.

Authors:  Jared J Aumiller; Donald L Jarvis
Journal:  Protein Expr Purif       Date:  2002-12       Impact factor: 1.650

5.  In vitro selection of structure-switching, self-reporting aptamers.

Authors:  Seung Soo Oh; Kory Plakos; Xinhui Lou; Yi Xiao; H Tom Soh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

6.  Distinct rpsC single nucleotide polymorphism lineages of Flavescence dorée subgroup 16SrV-D phytoplasma co-infect Vitis vinifera L.

Authors:  F Quaglino; P Casati; P A Bianco
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

7.  A method for clone sequence confirmation using a mismatch-specific DNA endonuclease.

Authors:  Peter Qiu; Harini Shandilya; Gary F Gerard
Journal:  Mol Biotechnol       Date:  2005-01       Impact factor: 2.695

8.  Gene enrichment in maize with hypomethylated partial restriction (HMPR) libraries.

Authors:  John Emberton; Jianxin Ma; Yinan Yuan; Phillip SanMiguel; Jeffrey L Bennetzen
Journal:  Genome Res       Date:  2005-10       Impact factor: 9.043

9.  Unmasking Anticooperative DNA-binding interactions of vaccinia DNA topoisomerase I.

Authors:  Rajesh Nagarajan; James T Stivers
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

10.  A universal cloning vector using vaccinia topoisomerase I.

Authors:  Liang Geng; Wen Xin; Da-Wei Huang; Gui Feng
Journal:  Mol Biotechnol       Date:  2006-05       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.